[1]
A. Tomaszuk-Kazberuk and J. Małyszko, “Benefits of lisinopril therapy in cardiovascular and kidney diseases. Our expectations after HALT-PKD trial”, J EBM, vol. 5, no. 4(17), pp. 14-20, Dec. 2012.